Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. Dr. Hoke’s clinical practice focuses on peripheral neuropathies and nerve injuries. His clinical research focuses on idiopathic, toxic, and inflammatory neuropathies and he is the principal investigator of several natural history studies aimed at developing biomarkers and understanding genetic underpinnings of peripheral neuropathies. His basic research focuses on studies of biology of peripheral axons and Schwann cells and disorders affecting the peripheral nervous system, utilizing in vitro and in vivo models of peripheral neuropathies to study the mechanisms of axonal damage and identify therapeutic targets for drug development. In addition, he has a research interest on mechanisms of axonal regeneration, specifically on chronic nerve injury models that recapitulate the challenges of human nerve regeneration. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. Dr. Hoke’s clinical practice focuses on peripheral neuropathies and nerve injuries. His clinical research focuses on idiopathic, toxic, and inflammatory neuropathies and he is the principal investigator of several natural history studies aimed at developing biomarkers and understanding genetic underpinnings of peripheral neuropathies. His basic research focuses on studies of biology of peripheral axons and Schwann cells and disorders affecting the peripheral nervous system, utilizing in vitro and in vivo models of peripheral neuropathies to study the mechanisms of axonal damage and identify therapeutic targets for drug development. In addition, he has a research interest on mechanisms of axonal regeneration, specifically on chronic nerve injury models that recapitulate the challenges of human nerve regeneration. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology.

• 

  Scientific and Clinical in HDAX Therapeutics

  We are dedicated to bringing transformative therapies to patients – empowering them to embrace life to its fullest.